Hamilton, Waterloo ON
Hyivy Health creates a pelvic rehabilitation system for women experiencing symptoms from pelvic cancers and diseases. Our device provides 3 different therapies for more effective and comfortable rehab experiences as well as provides the first quantifiable data set on the pelvic floor using biosensors and tracked by doctors on our clinical software portal.
One in three women will experience pelvic health problems in their lifetime. There are over 300M women worldwide diagnosed with a pelvic disease who deal with multiple debilitating symptoms daily. These problems have a direct impact on the quality of life for women and are not curable.There are 50M women demanding pelvic health treatments in North America and only 5,400 trained pelvic floor therapists to treat them.
The idea for Hyivy was created out of Rachel Bartholomew’s recent fight with cervical cancer. On bed rest, she came up with the idea and did problem validation with over 54,000 women in gynecological cancer Facebook support groups and she used her radiation treatments as a way to pitch to the doctors treating her for medical validation.
We are the first to collect, track and quantify progress on multiple data points on the pelvic floor. We are the first to alleviate a number of symptoms at once while providing the proper educational materials and including doctors in the treatment planning process to increase successful patient outcomes. Our device and its system is patent pending, has a first mover advantage on the data elements of our solution and has the potential to standardize pelvic health treatment worldwide.
We are currently seeking to connect with Canadian manufacturers who are capable of manufacturing medical grade products, investors who are interested in women’s health and medical devices, potential customers in pelvic floor therapy and OBGYN services and research partners in the areas of pelvic health.
We are always looking to connect with large medical device companies, insurance providers, femtech and women’s health leaders and regulatory consultants to talk about the path to market.